Homeopathic Treatment for Depression in Peri- and Postmenopausal Women

Launched by HOSPITAL JUAREZ DE MEXICO · Jul 3, 2012

Keywords

ClinConnect Summary

Perimenopausal period is characterized by an increased risk of depressive symptoms. Major depression is one of the most disabling medical conditions worldwide. At present, it is becoming more difficult to prove that antidepressants actually work better than placebo in clinical trials.Use of homeopathy to treat depression is widespread, but there is a lack of clinical trails about its efficacy in depression in peri- and postmenopausal women. Previous trials suggest that individualized homeopathic treatments improve depression in general population. The purpose of this study was to determine ...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Major depression according to DSM-IV
• • Moderate to severe depression according to 17-item Hamilton Rating Scale for Depression (14-24 score)
• • No current use of homeopathic treatment for depression or antidepressants or anxiolytic drugs 3 months prior to study entry
• • Not be currently taking psychotherapy for at least 3 months before study entry
• • Early transition to menopause defined by a change in cycle length of 7 days or longer in either direction from the participant´s own baseline for at least 2 cycles
• • Late transition to menopause defined as 3 to 11 months of amenorrhea
• • Postmenopausal stage defined by 12 months or more of amenorrhea
• • Capability and willingness to give informed consent and to comply with the study procedures
• Exclusion Criteria:
• • Pregnancy or breastfeeding
• • Other psychiatric disorders different from moderate to severe depression (severe depression, schizophrenia, psychotic disorders, bipolar affective disorders, suicide attempt)
• • Alcohol or other substance abuse
• • Known allergy to fluoxetine
• • Cancer or hepatic diseases